Tamoxifen - Risks and opportunities

被引：0

|

作者：

Martin, EA ^{[1
]}

机构：

[1] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England

来源：

TOXICOLOGY | 2001年 / 168卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：20 / 27

页数：8

相关论文

共 50 条

[1] Chemoprevention of breast cancer by tamoxifen: Risks and opportunities
Smith, LL
Brown, K
Carthew, P
Lim, CK
Martin, EA
Styles, J
White, INH
[J]. CRITICAL REVIEWS IN TOXICOLOGY, 2000, 30 (05) : 571 - 594
[2] Chemoprevention of breast cancer by tamoxifen: Risks and opportunities
Smith, LL
White, INH
[J]. TOXICOLOGY LETTERS, 1995, 82-3 : 181 - 186
[3] RESTATING THE RISKS OF TAMOXIFEN
SEACHRIST, L
[J]. SCIENCE, 1994, 263 (5149) : 910 - 911
[4] Weighing the risks and benefits of tamoxifen
Greiver, M
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2003, 168 (01) : 12 - 13
[5] Tamoxifen, balancing risks and benefits
Bergman, L
Benraadt, J
vanLeeuwen, FE
[J]. NETHERLANDS JOURNAL OF MEDICINE, 1996, 49 (06): : 228 - 234
[6] Considering the risks and benefits of tamoxifen
[J]. Reactions Weekly, 1998, 711 (1) : 3 - 3
[7] Weighing the risks and benefits of tamoxifen - Response
Gail, M
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2003, 168 (01) : 13 - 13
[8] The Underrated Risks of Tamoxifen Drug Interactions
Philip D. Hansten
[J]. European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 495 - 508
[9] Tamoxifen and menopausal status: Risks and benefits
Sasco, AJ
[J]. LANCET, 1996, 347 (9003): : 761 - 761
[10] The Underrated Risks of Tamoxifen Drug Interactions
Hansten, Philip D.
[J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (05) : 495 - 508

← 1 2 3 4 5 →